El Salvador vs Netherlands: The number of people with susceptibility test result for rifampicin
El Salvador
316
in 2021
Netherlands
270
in 2021
El Salvador rank
87th
Netherlands rank
88th
The number of people with susceptibility test result for rifampicin over time
- El Salvador
- Netherlands
How they compare
El Salvador currently reports 316 against 270 in Netherlands, a difference of 46.
That makes El Salvador's figure about 1.2 times Netherlands's.
Across all 5 years both countries report, El Salvador has been ahead every year.
El Salvador ranks 87th and Netherlands ranks 88th of 155 countries.
El Salvador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | El Salvador | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 844.33 | 322.33 | 522 | El Salvador |
| 2020s | 418.5 | 257 | 161.5 | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, El Salvador or Netherlands?
- El Salvador, at 316 against 270 in Netherlands as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between El Salvador and Netherlands?
- 46, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Netherlands?
- 5 years are reported by both, from 2017 to 2021.
- How do El Salvador and Netherlands rank globally for the number of people with susceptibility test result for rifampicin?
- El Salvador ranks 87th and Netherlands ranks 88th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.